Positional therapy can be a long-lasting and effective treatment for patients with positional obstructive sleep apnea (OSA), according to research presented at the 2026 ATS International Conference.
New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...
Researchers have discovered that certain patients with obstructive sleep apnea and obesity may experience much greater benefits from the GLP-1 medication tirzepatide than others. The findings could ...
Apple has announced the rollout of two new device features in India: sleep apnea notifications for Apple Watch, and Hearing ...
Tirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, ...
Wearables like the Apple Watch and Oura Smart Ring often have substantial positive impacts on the health and fitness ...
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...
Standard treatment for obstructive sleep apnea has long relied on continuous positive airway pressure machines, but new ...
May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...
AD109, an investigational once-daily oral combination of aroxybutynin and atomoxetine, significantly improved airway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results